Can CBD Gummies Make You Depressed? Insights from Pathologica
CBD depression drug safety dosing is a critical topic for clinicians and patients alike. Current evidence shows mixed effects of CBD on mood, requiring careful monitoring. Understanding dosing and product quality is essential to avoid worsening…
Tennessee Lawmakers Vote To Block Potential State Medical Marijuana Legalization After Federal Rescheduling
Tennessee medical marijuana legislation has recently blocked potential legalization despite federal rescheduling efforts. This state-level prohibition limits patient access to cannabis therapies. Clinicians must navigate these restrictions while staying…
Addiction Policy Forum Launches Cannabis Use Disorder Prevention and Awareness Week
Cannabis use disorder prevention strategies are critical as cannabis use rises. The Addiction Policy Forum has launched an awareness week to promote these strategies. Early identification and intervention can reduce the impact of cannabis use disorder.
Frequent Social Media Use Linked to Cannabis Use in Adolescents
Recent research highlights adolescent cannabis use and social media as strongly linked factors. Frequent social media use may increase cannabis initiation risk among youth. Clinicians should screen for both to guide prevention and counseling.
Myth Masquerading as Science: CU Anschutz Addiction Psychiatrist Investigates Cannabis Brain Development Risks
This article examines cannabis brain development risks, challenging the myth that brain maturation continues until age 25. CU Anschutz addiction psychiatrist Dr. Bryon Adinoff reviews the evidence and finds limited support for this claim. Understanding…
Review Finds Limited Evidence for Cannabis in Treating Mental Health Disorders
A recent review highlights limited evidence cannabis mental health benefits for conditions like PTSD and anxiety. The study emphasizes the need for more rigorous research. Clinicians should consider cannabis as adjunctive, not primary, therapy.
Ask the Expert: How Is Cannabis Use Disorder Diagnosed and Treated?
Cannabis use disorder diagnosis criteria are essential for identifying this underrecognized condition. Treatment options focus on behavioral therapies and managing withdrawal symptoms. Understanding these criteria helps clinicians provide better care.
How Psychedelics Came to Be Placed Under the Strictest International Control
Understanding the psychedelic drug regulatory history is essential as these compounds advance through FDA approval and clinical integration. The strict international control has created significant research barriers. This history shapes current patient…
Potent Pot Fuels Psychotic Episodes, ER Visits: ‘America Has a Marijuana Problem’ – CBN
Cannabis-induced psychotic episodes are increasingly reported in emergency departments, often linked to high-potency THC products. These episodes require clinical recognition and careful triage. Understanding cannabis-induced psychotic episodes is vital…
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin mushrooms regulation is lagging behind their mainstream adoption, creating clinical risks. Scientific research on psilocybin remains limited, complicating safe patient care. Clinicians must navigate drug interactions and screening to ensure…